Relative Survival Analysis Using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007
Source:J Registry Manag. 41(2):72-76.
Aged, 80 And Over
Centers For Disease Control And Prevention (U.S.)
NPCR Cancer Surveillance System
Population-based Central Cancer Registries
Public Health Surveillance
Relative Survival Rates
Reproducibility Of Results
Pubmed Central ID:PMC4361070
Funding:DFO8/Intramural CDC HHS/United States
Cancer survival rates are important to evaluate cancer care, identify disease patterns, and to estimate the probability of death due to cancer. To date, survival rates have been calculated using other data sets with limited population coverage that may not be able to fully identify differences by treatment, geographic regions, and racial or ethnic groups. Data from the Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (NPCR) have not previously been used to calculate relative survival rates within the United States.
Data from CDC's November 2011 submission for 21 state population-based central cancer registries, representing 50% of the U.S. population, were included in this analysis. This paper presents relative survival rates for diagnosis years 2000-2007 with follow-up through 2008.
The relative survival rate for all cancers and races combined was 65.0%; 65.3% for males, 64.8% for females. Blacks had a lower relative survival rate than whites, except for lung and bronchus. For all cancers, the <45 age groups had the highest relative survival rates, except for black males.
For all cancer primary sites combined for 2000-2007, the CDC NPCR five-year relative survival rate is comparable to that reported by the National Cancer Institute and the Canadian Cancer Registry. This analysis presents, for the first time, relative survival rates for half of the total U.S. population and demonstrates that reliable survival rates can be calculated using CDC's NPCR data now and in the future.
You May Also Like: